Structure-Activity Relationships in Salinomycin: Cytotoxicity and Phenotype Selectivity of Semi-synthetic Derivatives

Björn Borgström1, Xiaoli Huang2, Cecilia Hegardt3

  • 1Centre for Analysis and Synthesis, Lund University, Box 124, 22100, Lund, Sweden.

Insights

Salinomycin derivatives were synthesized to target cancer stem cells. Certain 20-O-acylated analogues show enhanced selectivity and activity, highlighting the importance of ionophore properties for cancer therapy.

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Molecular Pharmacology

Background:

  • Cancer stem cells (CSCs) are implicated in tumor recurrence, metastasis, and drug resistance.
  • Salinomycin selectively reduces CSC populations, making it a promising therapeutic lead.
  • Developing novel salinomycin derivatives is crucial for understanding its mechanism and improving efficacy.

Purpose of the Study:

  • To synthesize and evaluate structural derivatives of salinomycin.
  • To establish structure-activity relationships for cytotoxicity and CSC phenotype selectivity.
  • To probe the role of ionophore properties in salinomycin's anti-CSC effects.

Main Methods:

  • Synthesis of salinomycin analogues targeting accessible functional groups.
  • Assessment of cytotoxicity against cancer cell lines.
  • Evaluation of phenotype selectivity in breast cancer cells.
  • Structure-activity relationship (SAR) analysis.

Main Results:

  • A library of salinomycin analogues was generated and tested.
  • 20-O-acylated derivatives demonstrated improved selectivity and activity against CSCs.
  • Modifications disrupting ion coordination (C11 ketone, C1 carboxylate) abolished activity, confirming the role of ionophore function.

Conclusions:

  • Novel salinomycin derivatives, particularly 20-O-acylated analogues, offer enhanced anti-CSC potential.
  • The ionophore activity of salinomycin is critical for its ability to target CSCs.
  • These findings provide a basis for developing more effective CSC-targeting cancer therapies.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
4.0K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.4K